Provided by Tiger Fintech (Singapore) Pte. Ltd.

DiaMedica Therapeutics Inc.

6.41
+0.48008.09%
Post-market: 6.410.00000.00%16:57 EST
Volume:1.02M
Turnover:6.63M
Market Cap:331.33M
PE:-9.29
High:6.74
Open:5.89
Low:5.80
Close:5.93
52wk High:7.49
52wk Low:3.19
Shares:51.69M
Float Shares:32.94M
Volume Ratio:2.20
T/O Rate:3.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6903
EPS(LYR):-0.6050
ROE:-64.12%
ROA:-38.33%
PB:6.42
PE(LYR):-10.60

Loading ...

DiaMedica Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
Aug 09

DiaMedica Therapeutics Appoints Julie Krop, Md, as Chief Medical Officer

THOMSON REUTERS
·
Aug 06

BRIEF-Diamedica Therapeutics To Report Second Quarter 2025 Financial Results And Provide A Business Update August 13, 2025

Reuters
·
Aug 06

DiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025

THOMSON REUTERS
·
Aug 06

DiaMedica Therapeutics Inc Files for Resale of up to 8.6 Mln Common Shares by the Selling Shareholders - SEC Filing

THOMSON REUTERS
·
Aug 01

DiaMedica Therapeutics Inc expected to post a loss of 19 cents a share - Earnings Preview

Reuters
·
Aug 01

Jan Stahlberg, 10% Owner, Reports Acquisition of Common Shares in DiaMedica Therapeutics Inc

Reuters
·
Jul 26

Thomas Von Koch, 10% Owner, Reports Acquisition of Common Shares in DiaMedica Therapeutics Inc

Reuters
·
Jul 26

Richard Jacinto II Reports Acquisition of Common Shares in DiaMedica Therapeutics Inc

Reuters
·
Jul 26

DiaMedica Therapeutics Closes $30.1 Million Private Placement to Advance Clinical-Stage Biopharmaceutical Initiatives

Reuters
·
Jul 24

DiaMedica Therapeutics Announces Closing of $30.1 Million Private Placement

THOMSON REUTERS
·
Jul 24

DiaMedica Therapeutics to Raise $30 Million Via Private Placement

MT Newswires Live
·
Jul 21

Diamedica Therapeutics Is Maintained at Buy by Lake Street

Dow Jones
·
Jul 18

DiaMedica Therapeutics Announces Promising Interim Phase 2 Results for Preeclampsia Treatment with DM199, Showing Significant Blood Pressure Reduction and No Placental Transfer

Reuters
·
Jul 17

DiaMedica Therapeutics Joins Russell 2000 and 3000 Indexes

Reuters
·
Jun 24

Diamedica Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
May 29